CPDU to Participate in Upcoming Investment Conferences

China Pediatric Pharmaceuticals, Inc. (OTC Bulletin Board: CPDU) ("China Pediatric Pharmaceuticals" or the "Company"), today announced that Mr. Jun Xia, the Company's CEO, and Mr. Minggang Xiao, CFO and Ms. Lijuan Feng, VP, Corporate Affairs will present at the Rodman & Renshaw Annual Global Investment Conference, to be held on September 12-15, 2010 at the New York Palace Hotel, in New York, NY.

The date, time, and location of China Pediatric Pharmaceuticals, Inc’s presentation at the Rodman & Renshaw Annual Global Investment Conference are as follows:

China Pediatric Pharmaceuticals, Inc 's presentation is part of the China track that will be showcased during the Rodman & Renshaw Annual Global Investment Conference and will feature more than 120 Chinese companies from the Agriculture, Auto, Cleantech & Energy, Consumer/Retail, Education, Healthcare, Industrial and Technology industries. In addition to China, the Conference will highlight industry tracks including healthcare, metals and mining, energy, technology, cleantech, community and regional banks, and REITs.

The 3-day conference consists of 25-minute presentation slots followed by 10-minute open floor Q&A sessions with institutional clients. The gathering of presenting companies, senior management, and industry experts, as well as institutional investors, will enjoy a unique and comprehensive look at China on a global scale. For more information about the conference, please visit http://www.rodm.com/conferences .

About China Pediatric Pharmaceuticals, Inc

China Pediatric Pharmaceuticals, Inc. has its headquarters in Xi’an, Shaanxi Province, China. The Company identifies, discovers, develops manufactures and distributes both prescription and over-the counter, including both conventional and Traditional Chinese Medicines (“TCMs”), pharmaceutical products for the treatment of some of the most common ailments and diseases, with pediatric medicine as its focus. The Company’s manufacturing facility located in Baoji City, Shaanxi Province. The Company distributes its high value, branded medicines, both prescription and OTC, through exclusive territory agents who sell our products directly to local pharmacies who in turn sell them to their retail customers. For the six months ended June 30, 2010，Revenue was $13,217,661 and Net Income was $2,725,257 or $ 0.29 per share. As at June 30, 2010, Shareholders’ Equity was $20,280,504 and Total Assets were $24,322,864.

Cautionary Statement Regarding Forward-Looking Information

This release may include "forward-looking statements." You can identify these statements by the fact that they do not relate strictly to historical or current facts. These statements contain such words as "may," "project," "might," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or the negative or other variations thereof or comparable terminology. These forward-looking statements are based on current expectations and projections about future events. Investors are cautioned that forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties that cannot be predicted or quantified and, consequently, our actual performance may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the following factors, as well as other factors described from time to time in our reports filed with the Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.